Literature DB >> 15150131

Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.

Eun Young Park1, Il Je Cho, Sang Geon Kim.   

Abstract

Cancer chemopreventive agents transcriptionally induce glutathione S-transferase (GST), which can protect cells from chemical-induced carcinogenesis. Activation of either NF-E2-related factor-2 (Nrf2) or the CCAAT/enhancer binding protein-beta (C/EBPbeta) contributes to GST induction. Peroxisome proliferator-activated receptor-gamma (PPARgamma) and the retinoic acid X receptor (RXR) play roles in regulating cell differentiation and chemoprevention. This study examined GSTA2 gene induction by the PPARgamma activator and 9-cis-retinoic acid (RA), a RXR ligand, and investigated the molecular basis of PPAR-RXR-mediated GSTA2 induction in the H4IIE hepatocytes. Either 15-deoxy-delta (12, 14)-prostaglandin J(2) (PGJ(2)) or RA induced GSTA2 with Nrf2 and C/EBPbeta activation. When compared with PGJ(2) or RA alone, PGJ(2) + RA enhanced GSTA2 induction, with increases in Nrf2 and C/EBPbeta activation. PGJ(2) + RA increased the luciferase reporter gene activity in the cells transfected with the -1.65-kb flanking region of the GSTA2 gene. Thiazolidinedione PPARgamma agonists, troglitazone, rosiglitazone, and pioglitazone, in combination with RA, potentiated GSTA2 induction, confirming that the activation of the PPARgamma and RXR heterodimer contributed to GSTA2 expression. Deletion of the antioxidant response element- or C/EBP-binding sites or the overexpression of dominant-negative mutant of C/EBP abolished the reporter gene expression. PGJ2 + RA increased the binding of the PPARgamma - RXR heterodimer to the putative PPAR-response elements (PPREs) in the GSTA2 promoter. Specific mutations of these multiple PPRE sites resulted in the complete loss of its responsiveness to PGJ2 + RA, which suggests that these binding sites function as a PPRE-responsive enhancer module (PPREM). Transactivation of PPREM by the PPARgamma - RXR heterodimer was verified by the effective GSTA2 induction in the cells treated with PGJ2 + RA after transfecting them with the plasmids encoding PPARgamma1 and RXRalpha. In conclusion, the PPARgamma - RXR heterodimer promotes GSTA2 induction by activating PPREM in the GSTA2 gene, as well as inducing Nrf2 and C/EBPbeta activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150131     DOI: 10.1158/0008-5472.CAN-03-3924

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

2.  Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver.

Authors:  Sana Raza-Iqbal; Toshiya Tanaka; Motonobu Anai; Takeshi Inagaki; Yoshihiro Matsumura; Kaori Ikeda; Akashi Taguchi; Frank J Gonzalez; Juro Sakai; Tatsuhiko Kodama
Journal:  J Atheroscler Thromb       Date:  2015-06-04       Impact factor: 4.928

Review 3.  Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.

Authors:  Xiu-Rong Zhao; Nicole Gonzales; Jaroslaw Aronowski
Journal:  CNS Neurosci Ther       Date:  2014-11-28       Impact factor: 5.243

Review 4.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

5.  Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.

Authors:  Massimo F L Pomponi; Giovanni Gambassi; Massimiliano Pomponi; Carlo Masullo
Journal:  Aging Dis       Date:  2010-07-12       Impact factor: 6.745

6.  Nrf2-dependent gene expression is affected by the proatherogenic apoE4 genotype-studies in targeted gene replacement mice.

Authors:  Anne-Christin Graeser; Christine Boesch-Saadatmandi; Jana Lippmann; Anika E Wagner; Patricia Huebbe; Niels Storm; Wolfgang Höppner; Ingrid Wiswedel; Andreas Gardemann; Anne M Minihane; Frank Döring; Gerald Rimbach
Journal:  J Mol Med (Berl)       Date:  2011-05-28       Impact factor: 4.599

7.  Decreased detoxification genes and genome size make the human body louse an efficient model to study xenobiotic metabolism.

Authors:  S H Lee; J S Kang; J S Min; K S Yoon; J P Strycharz; R Johnson; O Mittapalli; V M Margam; W Sun; H-M Li; J Xie; J Wu; E F Kirkness; M R Berenbaum; B R Pittendrigh; J M Clark
Journal:  Insect Mol Biol       Date:  2010-06-14       Impact factor: 3.585

Review 8.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.

Authors:  Ramya Kapadia; Jae-Hyuk Yi; Raghu Vemuganti
Journal:  Front Biosci       Date:  2008-01-01

9.  Combination Therapy of PPARgamma Ligands and Inhibitors of Arachidonic Acid in Lung Cancer.

Authors:  Jordi Tauler; James L Mulshine
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

10.  Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease.

Authors:  Tommaso Mello; Simone Polvani; Andrea Galli
Journal:  PPAR Res       Date:  2009-09-14       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.